HLB Therapeutics.
₩8,690
2
-₩210-2.36% Friday 06:30
Statistik
Harga Tertinggi Hari Ini
8,900
Harga Terendah Hari Ini
8,500
52M Tinggi
17,700
52M Rendah
2,840.58
Volume
328,420
Rata-Rata Volume
1,072,974
Kap Pasar
685.27B
Rasio P/E
-
Hasil Dividen
-
Dividen
-
Pendapatan
13MayDiharapkan
EPS yang Diharapkan
T/A
EPS Aktual
T/A
Orang Juga Mengikuti
Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti 115450.KQ. Ini bukan rekomendasi investasi.
Peserta
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Seegene
096530.KQ
Kap Pasar1.17T
Celltrion Health Care
091990.KQ
Kap Pasar11.33T
Access Bio
950130.KQ
Kap Pasar224.17B
Tentang
HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrical and electronic components, such as motors, pumps, and transformers. The company was formerly known as G-treeBNT Co., Ltd. and changed its name to HLB Therapeutics Co.,Ltd. in December 2021. HLB Therapeutics Co.,Ltd. was founded in 2000 and is headquartered in Seongnam, South Korea.
Show more...
CEO
Mr. Doug Jang
Karyawan
98
Negara
KR
ISIN
KR7115450009